
Legal in several countries, including Canada, Germany, and parts of the U.S., cannabis is used worldwide and widely promoted as a wellness product. However, as its popularity rises and more people consume it, its potential health risks are often overlooked. Now, a large systematic review strengthens evidence linking cannabis use to major adverse cardiovascular events, suggesting it should be considered a risk factor for heart disease.
Conducted by researchers from France and published in Heart, the study examined 24 pharmacoepidemiological papers (selected from an initial 3,012 records) over 7 years. The final analysis included 17 cross-sectional studies, six cohort studies, and one case-control study, with approximately 432 million participants. Cannabis use was considered the primary exposure variable in all studies, with one study focused on medical cannabis.
The researchers assessed study quality using the ROBINS-E tool (Risk of Bias in Non-Randomized Studies of Exposure). For the meta-analysis, the researchers pooled adjusted effect estimates and their 95% confidence intervals using a DerSimonian-Laird random effects model with inverse variance weighting, based on the type of outcome studied.